← FDA Drug Approvals (Drugs@FDA)

IDVYNSO

NDA · New Drug Application · Sponsor: MSD · Approved 2026-04-20

Drug application

FDA Application #

NDA216964

Application type

New Drug Application

Brand name

IDVYNSO

Generic name

DORAVIRINE, ISLATRAVIR

Active ingredients

DORAVIRINE; ISLATRAVIR

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MSD

Manufacturer

Merck Sharp & Dohme LLC

First approval

2026-04-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown